Aztreonam
Aztreonam for Injection, USP
Approved
Approval ID
d4500795-3b07-4a7d-b432-73cafbb3dbc6
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 9, 2024
Manufacturers
FDA
Hospira, Inc.
DUNS: 141588017
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Aztreonam
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0409-0829
Application NumberANDA206517
Product Classification
M
Marketing Category
C73584
G
Generic Name
Aztreonam
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateJanuary 9, 2024
FDA Product Classification
INGREDIENTS (2)
ARGININEInactive
Quantity: 780 mg in 1 1
Code: 94ZLA3W45F
Classification: IACT
AZTREONAMActive
Quantity: 1 g in 1 1
Code: G2B4VE5GH8
Classification: ACTIB
Aztreonam
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0409-0830
Application NumberANDA206517
Product Classification
M
Marketing Category
C73584
G
Generic Name
Aztreonam
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateJanuary 9, 2024
FDA Product Classification
INGREDIENTS (2)
AZTREONAMActive
Quantity: 2 g in 1 1
Code: G2B4VE5GH8
Classification: ACTIB
ARGININEInactive
Quantity: 1.56 g in 1 1
Code: 94ZLA3W45F
Classification: IACT